acute myeloid leukemia
Expression of CD56 in acute myeloid leukemia (AML) is associated with poor outcome when patients treated with stem cell transplant in second remission but not in the first remission.
Expression of CD56 in acute myeloid leukemia ( AML ) is associated with poor outcome when patients treated with stem cell transplant in second remission but not in the first remission .